tbuckley/cabot-search huggingface dataset:
SYPHILIS.
Authors: JOHN V. SHOEMAKER
Journal: JAMA (1898)

I have present today several well marked examples of constitutional syphilis. I bring them before you not because they are rare types, but because they collectively represent some of the most characteristic phases of the disease. <h3>MACULAR SYPHILIDE.</h3> This young man, 22 years of age, contracted a chancre three months ago. The period of incubation was sixteen days and the lesion lasted three weeks. Nine weeks and a half after inoculation, having regarded himself in the meantime as entirely well, he noticed that his hair came out when he used the brush. He also found a few small scattered papules upon his scalp. The hair has continued to fall and is now quite thin. The papules are of a coppery color. Upon his back and sides I observed what the patient had not yet detected, viz., a macular eruption. There have been no osteocopes or noticeable fever. His throat has
AMA SPECIALTY JOURNAL ABSTRACTS
Journal: JAMA (1986)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
SEA-WATER AND THE CELL.
Journal: JAMA (1900)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Internal Medicine
Authors: Eric Bernicker
Journal: JAMA (1994)

<b>The Internal Medicine Companion</b>, by Fred F. Ferri, 349 pp, paper, $24.95, ISBN 0-8016-7825-0, St Louis, Mo, Mosby, 1994. Textbooks of general internal medicine kill a lot of trees. Attempting to provide a comprehensive framework for the student, the house officer, and the practitioner, while keeping abreast of changes in medical knowledge, the text must avoid both superficiality and burdensome detail. The fourth edition of Jay H. Stein's<i>Internal Medicine</i>finds that balance. The 2861 pages of text, with 431 contributing authors and a 136-page index, provides a wonderful source for physicians in many venues. To review it for this journal, I did not read it from front to back but instead tried to use it as one might in practice: every day after morning report at our public teaching hospital, I looked up the topics that had come up for discussion. The strength of Stein continues to be its
Age-related breast cancer therapy
Authors: E. Shocket
Journal: JAMA (1987)

<h3>To the Editor.—</h3> In the May 22/29 issue of<i>JAMA</i>, Greenfield et al<sup>1</sup>report inappropriateness in the treatment of elderly patients with breast cancer, both with and without comorbidity. The article implies that the attending physicians were less than ideally aggressive in management. I write to compliment them on their study and to raise two points. First, what part did the patient herself, or her family, play in the rejecting of "appropriate" aggressive management; could the patient, or her family, have expressed the view that the patient was "too old?" Second, I challenge the study's<i>breast cancer criteria map</i>, which defined as appropriate an axillary dissection in elderly patients, including those too frail for effective chemotherapy. In its 1985 Consensus Development Conference statement, the National Institutes of Health agreed that chemotherapy was not appropriate in the postmenopausal patient.<sup>2</sup>Although medical oncologists in the United States occasionally do use
Abstract 3040: Coronary Artery Bypass Surgery In 14,956 Patients With Cardiogenic Shock: The Society Of Thoracic Surgeons National Database Experience
Authors: Rajendra H Mehta, Joshua D Grab, Sean M O’Brien, Donald D Glower, Jeffrey P Jacobs, John D Puskas, James S Gammie, Eric D Peterson
Journal: Circulation (2007)

Background . While only a small minority of patients undergo coronary artery bypass surgery (CABG) in the setting of cardiogenic shock (CS), these patients face a high risk for mortality and morbidity. There exist few studies that characterize clinical features and outcomes in CS patients undergoing CABG in contemporary community practice. Methods . We evaluated data of 14,956 patients with CS in comparison with 693637 without CS undergoing CABG between 2002 and 2005 at hospitals participating in the Society of Thoracic Surgeons National Database. Clinical, angiographic and operative features and in-hospital outcomes were studied in patients with and without CS. Results . Patients with preoperative CS constituted 2.1% of patients undergoing CABG yet accounted for 16% of all CABG deaths. These patients had greater comorbid conditions and left main disease and lower left ventricular ejection fraction. In-hospital events and length of hospital stay (median 96 vs. 36 days) were significantly higher in CS patients. Operative mortality was high (rising from 20% for isolated CABG, to 33% for CABG+ valve surgery, to 58% for CABG+ ventricular septal repair). While mortality for CABG surgery overall has declined significantly overtime (p for trend&lt; .0001), mortality for CS patients have not changed significantly over the 4 year study period (p= .07, Figure ). Conclusions . Patients with CS represents minority of patients undergoing CABG, yet with persistently high operative risks. These patients in fact account for 1 of every 7 deaths in patients undergoing CABG. Ongoing efforts are warranted to continuously develop and evaluate new strategies to improve outcomes of these patients.
New Definitions for Healthy Ranges of Alanine Aminotransferase, a Blood Test of Liver Function
Journal: Annals of Internal Medicine (2002)

Summaries for Patients2 July 2002New Definitions for Healthy Ranges of Alanine Aminotransferase, a Blood Test of Liver FunctionSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-137-1-200207020-00001 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail What is the problem and what is known about it so far?Alanine aminotransferase (ALT) is a blood test that doctors often use to evaluate patients for liver disease. High levels of ALT in a patient's blood suggest that he or she has liver disease. However, the test is not perfect. Many patients with liver disease have normal ALT levels. Infection with hepatitis C virus (HCV) and fatty deposits in the liver are two common reasons why people have abnormal ALT levels. The current “normal” ranges of ALT were defined before we knew about or could test for these conditions. ... Author, Article, and Disclosure InformationAffiliations: The summary below is from the full report titled “Updated Definitions of Healthy Ranges for Serum Alanine Aminotransferase Levels.” It is in the 2 July 2002 issue of Annals of Internal Medicine (volume 137, pages 1-9). The authors are D Prati, E Taioli, A Zanella, E Della Torre, S Butelli, E Del Vecchio, L Vianello, F Zanuso, F Mozzi, S Milani, D Conte, M Colombo, and G Sirchia.Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoUpdated Definitions of Healthy Ranges for Serum Alanine Aminotransferase Levels Daniele Prati , Emanuela Taioli , Alberto Zanella , Emanuela Della Torre , Sonia Butelli , Emanuela Del Vecchio , Luciana Vianello , Francesco Zanuso , Fulvio Mozzi , Silvano Milani , Dario Conte , Massimo Colombo , and Girolamo Sirchia Metrics Cited byLiver volume in thalassaemia major: relationship with body weight, serum ferritin, and liver function 2 July 2002Volume 137, Issue 1Page: I-37KeywordsAlanine aminotransferaseBlood donorsFatty liverHematologic testsInfectious diseasesInfectious hepatitisLiverLiver diseasesLiver function testsPatients ePublished: 2 July 2002 Issue Published: 2 July 2002 Copyright & PermissionsCopyright © 2002 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Announcement
Authors: Jane Irvine, Zachary M. Shnek, Donna E. Stewart, E. Micali, C. Giorgianni, F. Munaò, R. Brecciaroli, L. Salmaso, D. Germanò, Madelon Y. Bolling, Robert J. Kohlenberg, Nicoletta Sonino, Tommi Tolmunen, Jukka Hintikka, Anu Ruusunen, Sari Voutilainen, Antti Tanskanen, Veli-Pekka Valkonen, Heimo Viinamäki, George A. Kaplan, Jukka T. Salonen, Giovanni A. Fava, Jenny Guidi, Secondo Fassino, Paolo Leombruni, Federico Amianto, Giovanni Abbate-Daga, C. Abbate, Anne-Mette Hvas, Svend Juul, Per Bech, Ebba Nexø, Roland von Känel, Brigitte M. Kudielka, Renate Schulze, Marie-Louise Gander, Joachim E. Fischer, Erwin Lemche, Gisela Klann-Delius, Rainer Koch, Peter Joraschky, Bernd Löwe, Kerstin Gräfe, Stephan Zipfel, Steffen Witte, Bernd Loerch, Wolfgang Herzog, Sherry L. Grace, Susan E. Abbey
Journal: Psychotherapy and Psychosomatics (2004)
Antibodies to AIDS-associated retrovirus distinguish between pediatric primary and acquired immunodeficiency diseases
Authors: A. J. Ammann
Journal: JAMA (1985)

Antibody to acquired immunodeficiency syndrome (AIDS)-associated retroviruses (ARVs) was investigated in 68 pediatric patients with abnormalities of T-cell and/or B-cell immunity. All except seven patients conformed to a specific World Health Organization classification for immunodeficiency disease. These seven patients had polyclonal hypergammaglobulinemia and T-cell immunodeficiency. Six of the seven patients had antibody to ARV and had risk factors associated with AIDS. The one patient without antiviral antibody had no AIDS risk factors. No antibody was detected in 61 patients with other primary immunodeficiency disorders. We conclude that ARV first appeared in our population of immunodeficient pediatric patients prior to 1978, is associated with a distinctive immunologic phenotype consisting of polyclonal hypergammaglobulinemia and T-cell immunodeficiency, and does not appear as an opportunistic infection in other immunodeficiency disorders. Detection of the retrovirus associated with AIDS is of value in identifying infants and children who may have unique medical and social problems that occur with AIDS. (<i>JAMA</i>1985;253:3116-3118)
Prevalence of antibody to human immunodeficiency virus and hepatitis B surface antigen in blood samples submitted to a hospital laboratory. Implications for handling specimens
Authors: H. H. Handsfield
Journal: JAMA (1987)

The prevalence of hepatitis B surface antigen (HBsAg) and antibody to human immunodeficiency virus (HIV) was determined in serum or plasma specimens of 506 patients submitted to the clinical chemistry laboratory of an urban teaching hospital, and the results were correlated with "biohazard" warning labels on the specimens. Hepatitis B surface antigen, HIV antibody, or either of these were present in 32 (6.3%), 15 (3.0%), and 44 specimens (8.7%), respectively. Ten (67%) of 15 specimens with HIV antibody and nine (28%) of 32 with HBsAg bore biohazard labels. Among 473 unlabeled specimens, HIV antibody was present in five (1.1%), HBsAg was present in 23 (4.9%), and 27 (5.7%) contained either or both of these markers. All clinical and laboratory personnel should be vaccinated against hepatitis B and should handle all blood specimens as if they were infected, regardless of biohazard labeling. By fostering complacency in handling unlabeled specimens, the use of biohazard labels may paradoxically increase the risk that health care workers will be exposed to HIV and hepatitis B virus. (<i>JAMA</i>1987;258:3395-3397)
Ah Receptor: Relevance of Mechanistic Studies to Human Risk Assessment
Authors: Jon C. Cook, Kevin W. Gaido, William F. Greenlee
Journal: Environmental Health Perspectives (1987)

Studies of the toxic actions of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in numerous animal models and in human and animal cells in culture have established that the most characteristic pathologic lesions produced by this compound result from events initiated by the interaction of TCDD with a specific intracellular receptor protein, the Ah receptor. Although most research on the interaction of TCDD with the Ah receptor has focused on establishing involvement of this receptor complex in specific toxic responses, recent application of modern cell and molecular biology techniques is yielding new insights into the mechanism(s) of signal transduction. Elucidation of these mechanisms is essential for understanding the molecular basis of the cell and species specificity which is a hallmark of TCDD toxicity. This knowledge should provide the framework for development of a more toxicologically relevant risk assessment model.
Correlation between the Tissue Response and Asbestos Fiber Content
Authors: A. G. Heppleston
Journal: Environmental Health Perspectives (1974)

Asbestos fiber concentration increases in proportion to the degree of pulmonary fibrosis as far as the moderate grade. No such correlation occurs with severe asbestosis, nor with the morphological form which the fibrosis assumes, and here secondary factors may be concerned. Electron microscopy suggests that optically visible fibers constitute a reasonably constant proportion of the total irrespective of the pathological reaction. Light microscopy may thus afford a guide to the total asbestos concentration. Finally, the development of mesothelioma, whether of the pleura or the peritoneum, appears to be unrelated to the concentration of coated or uncoated asbestos fibers residing in the lung.
Hectic Fever.
Authors: Q. C. Smith
Journal: JAMA (1893)

Austin, Tex., Oct. 9, 1893. <h3>To the Editor:</h3> —After many years of special experience in the treatment of pulmonary consumption and its various complications, I find the prescription herewith enclosed the most efficient and least disturbing to combat hectic fever: R Phenocoll. Salicin āā gr. 48. Sulphate Hydrastiæ gr. 24. M. ft. 24 capsules. Sig: One capsule every four to eight hours, as may be necessary to cool or prevent hectic fever. Of course, such other treatment, local or constitutional, as may be indicated should be diligently administered. Yours truly,
The gastrointestinal tract. The canary of the body?
Authors: D. R. Dantzker
Journal: JAMA (1993)

Despite advances in diagnosis and treatment, the survival of patients admitted to a critical care unit remains disappointingly low. Too many patients die each year as a result of irreversible organ failure, and too many survivors suffer prolonged disabilities. At least some of this organ damage can be attributed to the development of tissue hypoxia and is potentially preventable. This remains one of the major challenges for critical care physicians. See also p 1203. The process of oxygen delivery from the environment to the tissue is complex. The first step in the process, oxygenation of the arterial blood, is well understood and can usually be adequately achieved, even in the sickest patient. The development of techniques to improve oxygenation of the arterial blood was clearly dependent on the development of effective ways to monitor the arterial PO2. Repeated measurement of arterial blood gases is routine in critically ill patients, and
Carcinoma, Amebiasis, Bladder Stimulation, Jejunostomy Discussed at Surgeons Meeting
Journal: JAMA (1964)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Commentaire de travail de B.-H. Min et al., pp. 472
Journal: Endoscopy (2008)

See also: Comparison of a novel teeth-protecting mouthpiece with a traditional device in preventing endoscopy-related complications involving teeth or temporomandibular joint: a multicenter randomized trialEndoscopy 2008; 40(06): 472-477DOI: 10.1055/s-2007-995647
Editorial Board
Authors: Christos Mantzoros, James Field, Hilton Head, Young-Bum Kim, Salman Azhar, George Bray, Jorge Calles-Escandon, Nc Charles, George Chrousos, Maria Dalamaga, Jean-Pierre Després, Sabrina Diano, Louis Elsas, John Miami, Gregory Fain, Henry Freund, New Ginsberg, Charles York, Jane Glueck, Abbas Cleveland, Fredric Kitabchi, Robert Stanford, Faidon Kraemer, Giuseppe Matarese, Nicholas Musi, San Antonio, Maria New, New York, Michael Pagliassotti, Fort Collins, Catherine Postic, Alan Robinson, Los Angeles, Despina Sanoudou, James Sowers, Peter Stacpoole, Yu-Hua Tseng
Journal: Metabolism (2010)
Food for Life.
Journal: JAMA (1953)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Speech Therapy
Authors: M. Ellis
Journal: BMJ (1965)

Many immunological abnormalities, including circulating immune complexes (CICs), have been described in patients with sarcoidosis. The relationship of these abnormalities to clinical states is uncertain. In 31 proven cases of sarcoidosis we used the Raji assay in the investigation of the relationship between disease activity and the presence of CICs. Circulating immune complexes (greater than 49 micrograms.ml-1) were found in 11 of 14 patients with evidence of recent significant disease deterioration, whereas only one of 17 patients with chronic stable sarcoidosis demonstrated CICs (p less than 0.001). At follow-up, it was found that eight of the 11 cases with active disease and detectable CICs had resolved clinically. Resolution was accompanied by normalization of CICs in seven and persistence in one. The remaining three patients did not improve clinically and continued to demonstrate CICs. Measurements of complement levels did not demonstrate any significant difference between the two groups of patients. It is concluded that elevated levels of CICs, as detected by the Raji assay, are commonly found in association with significantly deteriorating sarcoidosis, often normalize following disease improvement and, consequently, may have a useful clinical role as a marker of activity.
Five-year Follow-up Report on the Birmingham Survey of 1962
Journal: BMJ (1970)

In a diabetes survey 630 persons who had glycosuria or were age- and sex-matched were given a 50-g. oral glucose tolerance test (G.T.T.). Five years later the test was repeated in 527 (83·6%) cases. The original G.T.T.s were classed as normal or showing “G.T.T. diabetes,” “lag storage,” “renal glycosuria,” or “miscellaneous abnormalities.” Compared with the normal group in the first test those with G.T.T. diabetes showed a higher rate of conversion to “florid diabetes,” but many others with G.T.T. diabetes remained unchanged or became normal. The more abnormal the first test the more likely it was to progress to florid diabetes. Most lag storage curves remained unchanged or became normal, but a significant number converted to a diabetic abnormality. Renal glycosuria was an innocent peculiarity compared with other categories. The various “miscellaneous abnormalities” tended to change, and showed an excessive conversion to diabetes. The best separation between non-diabetic and diabetic at the follow-up test occurred at 135 mg./100 ml. Those in the diabetic categories at the original test showed a mortality slightly above that in the general population, comparable to that found in diabetics in general. New cases of florid diabetes appeared in the population which screened negative for glycosuria at the rate of 0·3 per 1,000 per annum.